Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Future of Axillary Staging in Early Breast Cancer: A Comparative Study: Sentinel Node Biopsy vs PET/MRI

NCT04829643 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT04829643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04829643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Future of Axillary Staging in Early Breast Cancer: A Comparative Study: Sentinel Node Biopsy vs PET/MRI
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2020
Completion date
October 30, 2024
Enrollment
246 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, early-stage breast cancer, sentinel lymph node